| # | Drug | Count |
|---|---|---|
| 0 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 12 |
| 1 | CAPECITABINE | 10 |
| 2 | FULVESTRANT | 7 |
| 3 | LETROZOLE | 7 |
| 4 | LETROZOLE TABLETS | 7 |
| 5 | PACLITAXEL | 7 |
| 6 | PALBOCICLIB | 7 |
| 7 | BEVACIZUMAB | 6 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 5 |
| 9 | RAMIPRIL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND ZINC CHLORIDE | 1 | 0.2000 |
| 1 | CETRORELIX ACETATE | 3 | 0.0047 |
| 2 | IBUPROFEN LYSINE | 2 | 0.0035 |
| 3 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 4 | VANDETANIB | 1 | 0.0006 |
| 5 | DAPRODUSTAT | 1 | 0.0005 |
| 6 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 7 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 12 | 0.0004 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| 9 | EPOETIN ALFA | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 2 | Estrogen Receptor Antagonist [EPC] | 7 | 0.0002 |
| 3 | Vitamin D Analog [EPC] | 3 | 0.0002 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Oxazolidinone Antibacterial [EPC] | 3 | 0.0001 |
| 6 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |